Carta al DirectorFormulación de sirolimus tópico al 0,4% para el tratamiento de angiofibromas facialesTopical sirolimus 0.4% formulation for treatment of facial angiofibromas
Under a Creative Commons license
open access
Cited by (0)
Copyright © 2011 SEFH. Published by Elsevier España, S.L. All rights reserved.